Answers are grounded in this paper and cite their sources.
Citrin Deficiency (CD) is a metabolic disorder caused by mutations in CITRIN/SLC25A13/AGC2 , which encodes the hepatic mitochondrial aspartate–glutamate carrier (AGC), CITRIN. Loss of CITRIN-mediated aspartate export from mitochondria, either as part of the malate–aspartate shuttle (MAS) or through independent transport activity, underlies key clinical features including hypoglycemia, hyperammonemia, and aversion to carbohydrates and alcohol. Progress in the research of CD mechanisms and therapies has been hindered by lack of adequate models for the condition. For example, the citrin knockout mouse fails to recapitulate the human CD phenotype in vivo, likely due to compensatory expression of the neuronal AGC isoform aralar in murine liver, while the double citrin/glycerophosphate dehydrogenase 2 (gpd2) knockout mouse might present confounding results due to global gpd2 ablation. These limitations underscore the need for a physiologically relevant disease model to support translational research. We generated a double knockout (DLKO) mouse combining global deletion of citrin with liver-specific deletion of aralar using Cre-LoxP technology, resulting in a marked reduction of mitochondrial AGC-MAS activity in hepatocytes. Primary hepatocytes were used to assess cytosolic NADH/NAD⁺ ratios, gluconeogenesis, and urea production. In vivo characterization included biochemical and behavioral analyses, as well as indirect calorimetry to evaluate systemic metabolism. DLKO hepatocytes exhibited elevated cytosolic NADH/NAD⁺ ratios, severely impaired glucose production from lactate, and reduced urea synthesis. These alterations translated in vivo into key features of CD, including hypoglycemia, limited urea cycle capacity, and marked hepatic triglyceride accumulation in the absence of overt liver injury. Behavioral analyses revealed aversion to alcohol and carbohydrates, closely mirroring patient’s food preferences. Importantly, DLKO mice exhibit sex-associated metabolic adaptations: males show growth retardation, hyperphagia, increased energy expenditure, and elevated circulating FGF21 levels, whereas females demonstrate normal food intake and a shift toward lipid metabolism without changes in FGF21. The DLKO mouse represents a robust and physiologically relevant model for the study of Citrin Deficiency. This model overcomes limitations of previous approaches, uncovers distinct systemic metabolic responses in males and females to hepatic MAS dysfunction, and provides a powerful platform for mechanistic studies and preclinical evaluation of therapeutic strategies for CD.
No takes yet. Share an insight, caveat, or question.
García-Lobo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: